Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Starlight Cardiovascular logo — Helping heal little hearts

Starlight Cardiovascular

Helping heal little hearts

Founded 2020 United States San Diego, United States 12 employees Grant Total: $13.64M Health Care, Medical Devices

General Information

Company Name Starlight Cardiovascular
Founded Year 2020
Location United States San Diego, United States
Employees 12
Industries Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Starlight Cardiovascular. To contact Starlight Cardiovascular, visit starlightcardio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Starlight Cardiovascular compare?

A PDF of Starlight Cardiovascular and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Starlight Cardiovascular soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Starlight Cardiovascular

Starlight Cardiovascular, founded in 2020 and headquartered in the United States, aims to revolutionize the treatment of pediatric Congenital Heart Defects (CHDs) with its innovative tools and devices. With a slogan of "Helping heal little hearts," the company is addressing a critical need in the healthcare industry. Approximately 1.3 million babies are born each year with a CHD, yet the tools available for treatment are primarily designed for adult conditions and anatomy. This limitation inspired Starlight Cardiovascular to develop a portfolio of devices specifically tailored for pediatric CHDs. By focusing on pediatric patients, the company aims to improve morbidity, mortality, and access to care in this vulnerable population. In March 2023, Starlight Cardiovascular secured a significant $2.16M grant investment from the National Heart, Lung and Blood Institute, affirming confidence in the company's mission and potential impact. This funding will likely fuel the development and testing of the pediatric-specific devices, furthering the company's reach in the field of pediatric cardiology. As the healthcare industry continues to prioritize specialized care for diverse patient groups, Starlight Cardiovascular's dedication to pediatric CHD treatment positions the company as a key player in advancing innovative solutions for children with heart conditions.

Business keywords: Pediatric healthcare, Medical devices, Congenital Heart Defects, Pediatric cardiology, Morbidity improvement, Mortality reduction, Access to care, Medical innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.00M 1
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute
01 May 2024
Grant $2.16M 1
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute
22 Mar 2023
Series A $9.48M 2
Catalytic Impact Foundation Bird B.
Catalytic Impact Foundation, Bird B.
04 Oct 2022
Grant Undisclosed 1
Consortium For Technology & Innovation in Pediatrics
Consortium For Technology & Innovation in Pediatrics
02 Aug 2021

Starlight Cardiovascular Alternatives & Competitors

View All Alternatives
Starlight Cardiovascular vs
Ventripoint Diagnostics Ltd.
Ventripoint Diagnostics Ltd. Canada

Using Artificial Intelligence (AI) to create 3D volumetric measurements from standard 2D Echo images...

Post-IPO Equity
18 employees
Analytics, Biotechnology
Starlight Cardiovascular vs
Liberate Medical
Liberate Medical United States

Helping Patients Take Their Next Breath

Grant
14 employees
Biotechnology, Health Care
Starlight Cardiovascular vs
Protaryx Medical
Protaryx Medical United States

Simple, reproducible, and fast transseptal crossing

Series A
2 employees
Health Care, Medical Devices
View all alternatives

FAQ About Starlight Cardiovascular

Helping heal little hearts
Starlight Cardiovascular was founded in 2020.
Starlight Cardiovascular is headquartered in San Diego, United States.
Starlight Cardiovascular operates in Health Care and Medical Devices. Its work centres on Pediatric healthcare, Medical devices, Congenital Heart Defects and Pediatric cardiology.
Starlight Cardiovascular has approximately 12 employees.
Starlight Cardiovascular has completed 4 funding rounds, raising a total of $13.64M. The latest funding stage is Grant.
Top alternatives and competitors to Starlight Cardiovascular include Ventripoint Diagnostics Ltd., Liberate Medical, Protaryx Medical, Occlutech, HAI Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Starlight Cardiovascular and Ventripoint Diagnostics Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Starlight Cardiovascular, https://bouncewatch.com/company/starlight-cardiovascular, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes